Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

omalizumab

omalizumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Xolair INJECTION, SUBCUTANEOUS 150 mg/mL, 75 mg/0.5 mL      
Xolair POWDER FOR INJECTION, SUBCUTANEOUS 150 mg      


Comments:

Xolair medication guide


Xolair is restricted to use in outpatient areas. 

Inpatients should use home supply if possible.

 

For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents 


Last updated: Mar. 19, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.